Physician profile
Sever C Surdulescu
NPI 1710998802
$16,155.55
in general payments reported to CMS, 2019-2025
55 companies · $3,344 in 2025
The $3,344 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,038 · 2020: $1,217 · 2021: $1,429 · 2022: $2,168 · 2023: $3,191 · 2024: $2,769 · 2025: $3,344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,158 · Travel and Lodging: $859 · Education: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,158.16 |
| Travel and Lodging | $859.15 |
| Education | $286.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,476.55 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,722.39 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Inspire Medical Systems, INC. | $1,313.44 | 2023-2025 | Inspire |
| Mylan Specialty L.P. | $931.66 | 2019-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $852.24 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| Regeneron Healthcare Solutions, INC. | $798.84 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $753.60 | 2019-2025 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $703.11 | 2020-2025 | Xywav |
| Genzyme Corporation | $625.00 | 2019-2025 | |
| Insmed, INC. | $533.47 | 2019-2025 | Arikayce |
| Harmony Biosciences LLC | $506.47 | 2020-2025 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $504.46 | 2020-2025 | Glassia, Cuvitru |
| Actelion Pharmaceuticals US, INC. | $452.51 | 2019-2025 | Opsumit, Uptravi |
| Paratek Pharmaceuticals, INC. | $359.50 | 2020-2025 | Nuzyra |
| Verona Pharma, INC. | $350.19 | 2025 | Ohtuvayre |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $330.71 | 2019-2021 | |
| Axsome Therapeutics, INC. | $313.04 | 2022-2025 | Sunosi |
| Ani Pharmaceuticals, INC. | $253.36 | 2024-2025 | Purified Cortrophin Gel |
| Philips North America LLC | $242.97 | 2019-2023 | |
| Genentech USA, INC. | $234.38 | 2019-2020 | |
| United Therapeutics Corporation | $179.61 | 2024-2025 | Tyvaso, Tyvaso |
| Electromed, INC. | $155.95 | 2019-2025 | Smartvest |
| Teva Pharmaceuticals USA, INC. | $126.60 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $121.40 | 2022-2025 | Acthar |
| Circassia INC. | $118.04 | 2019-2020 | |
| Gilead Sciences, INC. | $96.78 | 2021-2024 | |
| Amgen INC. | $96.77 | 2024-2025 | Tezspire |
| Sanofi-Aventis U.S. LLC | $84.99 | 2024 | |
| Azurity Pharmaceuticals, INC. | $74.16 | 2024 | Horizant |
| Baxter Healthcare | $70.30 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Pulmonx Corporation | $70.00 | 2020-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Merck Sharp & Dohme LLC | $64.88 | 2020-2023 | |
| Pfizer INC. | $57.23 | 2022-2023 | |
| Eisai INC. | $54.92 | 2020-2021 | |
| Csl Behring | $46.48 | 2024-2025 | Hizentra |
| Shire North American Group INC | $43.46 | 2019 | |
| Advanced Respiratory, INC | $41.13 | 2020-2021 | |
| Inogen, INC. | $36.02 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Arbor Pharmaceuticals, INC. | $35.19 | 2020-2021 | |
| Biomerieux INC | $34.94 | 2023 | |
| Masimo Corporation | $32.50 | 2019 | |
| Mallinckrodt Enterprises LLC | $30.64 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.33 | 2021-2022 | |
| Viatris Specialty LLC | $28.33 | 2025 | Yupelri |
| Nabriva Therapeutics, Plc | $23.73 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $23.42 | 2025 | Lumryz |
| Vapotherm INC | $22.73 | 2022 | |
| 3b Medical, INC. | $22.13 | 2025 | Luna |
| Novo Nordisk INC | $20.65 | 2020 | |
| Lilly USA, LLC | $20.20 | 2025 | Zepbound |
| Novartis Pharmaceuticals Corporation | $17.50 | 2024 | |
| Itamar Medical INC | $16.65 | 2025 | Watchpatone |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sever Surdulescu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.